Accumulating evidence suggests that hepcidin, a 25-residue peptide hormone, is the master regulator of iron metabolism. Further evidence suggests that the five N-terminal amino acids are crucial for mediating its biological function. With a histidine residue at position 3, this region also has the potential to bind bivalent metal ions. To characterize this hepcidin-metal interaction in detail, the present study utilizes electrospray MS to measure the binding of a range of metal ions to wild-type and mutant human and murine hepcidins. In addition, the biological effects of these point mutations were tested on Caco-2 and HEK-293T human cell lines and in mice. Our results show that hepcidin-25 can form complexes with copper, nickel and zinc; however, we failed to detect any hepcidin-25 binding to either ferric or ferrous ions. The greatest affinity observed was between hepcidin-25 and copper with a dissociation constant 1 μM. Substituting the histidine residue at position 3 in human hepcidin-25 and comparably the asparagine residue at position 3 in murine hepcidin-25 with an alanine residue markedly diminished the affinity for copper. The amino acid substitutions also decreased the biological activity of hepcidin-25; namely repression of ferroportin protein levels and hypoferraemia. In summary, the high affinity of hepcidin for copper suggests that hepcidin could bind copper in vivo and this may be of biological relevance.
INTRODUCTION
Overwhelming evidence has identified the mature 25-aminoacid hepatic anti-microbial peptide hepcidin as the master regulator of iron metabolism in man [1, 2] . It is now also clear that there are several pathways involved in the regulation of this peptide hormone, including inflammation, infection, erythropoietic demand, hypoxia and body iron status [3] . Although exactly which intracellular signalling pathways are responsible for regulating hepcidin remains to be unravelled, it is clear that hepcidin mediates its biological activity by interacting with the cellular iron efflux protein FPN (ferroportin), which is present in most cell types [4] . This hepcidin interaction results in the internalization and degradation of FPN decreasing cellular iron efflux [4, 5] . There is also emerging evidence that the process of cellular iron efflux is also likely to be dependent upon the multicopper oxidases ceruloplasmin and hephaestin [6] , which are thought to function as ferroxidases [7] [8] [9] .
The hepcidin gene encodes an 84-amino-acid pre-propeptide which is cleaved by furin to generate the biologically active 25-residue peptide (hepcidin-25). Hepcidin forms a distorted β-sheet, stabilized by four intramolecular disulfide bonds spanning residues 7-23, leaving a flexible six-residue N-terminal region [10, 11] . In addition to hepcidin-25, two shorter forms, hepcidin-20 and hepcidin-22, have been identified where the N-terminal five and three amino acids are missing respectively. These are thought to represent breakdown products of hepcidin-25 [12] . Hepcidin-20 has no effect on cellular iron efflux, but does appear to exert anti-bacterial and anti-fungal properties in vitro, albeit at supraphysiological concentrations [13, 14] . This suggests that the first five N-terminal amino acids of hepcidin are essential for mediating its role in regulating iron metabolism and this has been confirmed by the studies of Ganz and colleagues [15, 16] , which showed that sequential N-terminal amino acid deletion resulted in a stepwise loss of FPN binding and biological activity with >50 % loss upon removal of the first three amino acids (aspartic acid, threonine and histidine residues).
Melino et al. [17] have shown that the N-terminal region of hepcidin-25 is capable of binding bivalent copper and nickel ions via an ATCUN (amino-terminal Cu-Ni)-binding motif comprising the three N-terminal residues [17] . However, that study largely used truncated forms of hepcidin-25 and utilized both high concentrations of hepcidin and metal ions. In addition, these studies were unable to provide information on affinity or stoichiometry. Studies by Farnaud et al. [18, 19] suggest that hepcidin may bind iron, although this interaction was only ever observed under reducing conditions and not with disulfidebonded hepcidin (generally thought to be the biologically active form). These suggestions that hepcidin might bind metal ions, in particular copper, are interesting as disturbances of copper metabolism have been shown to lead to altered iron homoeostasis [7] [8] [9] . Although these defects are generally thought to be caused by decreased activity of the ferroxidases hephaestin and ceruloplasmin, an interaction between copper and hepcidin had not been considered. Thus the aim of the present study is to further characterize metal ion binding to hepcidin and, using mutation analysis, determine the critical amino acids within hepcidin responsible for binding. If hepcidin does bind metal ions with high affinity, then this could have major implications for the regulation of human iron metabolism.
EXPERIMENTAL

Materials
All peptides were synthesized by Alta Bioscience (University of Birmingham, Birmingham, U.K.) and provided as linear (reduced) peptides. These were allowed to spontaneously oxidize by dissolving at concentration of 0.1 mg/ml in 6 M urea/30 mM Mops (pH 7.0) and incubating overnight at room temperature (25
• C) with stirring as described previously [20] . Complete disulfide bridge formation was accompanied by an 8 Da decrease in mass in MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight) mass spectra. The folded hepcidin was purified by RP-HPLC (reverse-phase HPLC) on a C18 column (4.6 mm × 150 mm; Phenomenex) using a gradient of 0-60 % ACN (acetonitrile) in 0.1 % TFA and freeze-dried. Hepcidin concentrations were determined by the BCA (bicinchoninic acid) assay calibrated with BSA (Pierce). The sequences of the synthetic hepcidin peptides are as follows, with amino acid substitutions underlined: human hepcidin-25, DTHFPICIFCCGCCHRSKCGMCCKT; human hepcidin(H3A), DTAFPICIFCCGCCHRSKCGMCCKT; human hepcidin-20, ICIFCCGCCHRSKCGMCCKT; murine hepcidin-25, DTNFPICIFCCKCCNNSQCGICCKT; murine hepcidin-(N3A): DTAFPICIFCCKCCNNSQCGICCKT.
Hepcidin-25 was purified from urine after informed consent had been obtained from patients. The present study was approved by the Ethics Research Committee of the Medical University of Innsbruck (protocol number UN3479). The purification was based on the method of Park et al. [14] . Briefly, urine was centrifuged at 3000 g for 30 min, passed through a 0.45 μm filter and diluted 1:10 with water before loading on to a 50 ml weak-cation-exchange column (GE Healthcare, Vienna, Austria). After washing with 5 column volumes of 25 mM ammonium acetate, hepcidin was eluted with 5 % acetic acid. The eluate was freeze-dried, dissolved in 0.1 % TFA and applied to a 10 mm × 250 mm C18 column (catalogue no. 218TP510; GRACE/Vydac ® ), which was equilibrated with 0.1 % TFA/2 % ACN. Peptides were separated with an acetonitrile gradient of a 3.6% ACN increment/min for 5 min followed by a 1 % ACN increment/min for 25 min and a 3.5 % increment/min over 10 min followed by a 4 % increment/min for the final 5 min of the run at a flow rate of 1.5 ml/min. Hepcidin elution was monitored by MALDI-TOF MS.
Hepcidin MS
Mass spectra were acquired on a 7-T LTQ FT instrument (Thermo Fisher Scientific). Peptides were dissolved in 10 mM ammonium acetate, pH 6.8, and directly infused into the mass spectrometer at a flow rate of approx. 300 nl · min −1 using a Triversa Nanospray source (Advion Biosciences). The nanoelectrospray voltage was +1.7 kV. Data were collected for 1 min per sample. The fraction of hepcidin with bound metal ion was estimated from the relative peak heights of the triply charged ions of free hepcidin and hepcidin-metal complex. Where peaks corresponding to hepcidin with one, two or three metal ions bound were present, the heights of all three were added together to calculate the fraction of 'complex', i.e. hepcidin-metal complex containing at least one metal ion.
Effect of hepcidin on FPN expression in Caco-2 cells
The cell line Caco-2 was routinely cultured in Dulbecco's modified Eagle's medium (Gibco) with 10 % foetal calf serum, supplemented with 100 units/ml penicillin and 0.1 mg/ml streptomycin. At 14 days, post-confluence cells were challenged with either growth medium alone (control) or with (i) human hepcidin-25 peptide, (ii) human hepcidin-25(H3A) or (iii) hepcidin-20 at concentrations of 1 μM. Following 48 h of stimulation, cells were lysed and processed for Western blot analysis with a rabbit polyclonal antibody against FPN (1:1000 dilution; Alpha Diagnostics, San Antonio, TX, U.S.A.) and a mouse monoclonal anti-β-actin antibody (1:5000 dilution; Abcam, catalogue no. ab8226-100); the latter was employed for normalization of protein loading. All immunoreactive bands were then subject to densitometry analysis using NIH Image 1.62 software. 
Effect of hepcidin in a FPN
Animal model for testing the effect of hepcidin peptides
CD1 male mice (6 weeks old; mass 28-32 g) (Charles Rivers, Margate, Kent, U.K.) were subject to intraperitoneal injection with (i) 0.15 M NaCl (control), (ii) murine hepcidin-25 or (iii) murine hepcidin-25(N3A) (25 μg/mouse). At 4 h after injection, mice were anaesthetized and killed by cervical dislocation, and the blood was collected by cardiac puncture. Serum iron analysis was performed using a serum iron assay kit (Thermo Electron Corporation, Louisville, CO, U.S.A.), according to the manufacturer's instruction. All animal experiments were performed under the authority of a U.K. Home Office licence. Mice were fed with the RM1 diet (Scientific Diet Supplies, Witham, Essex, U.K.). Experiments were performed in triplicate.
RESULTS
Hepcidin MS
The mono-isotopic m/z value of the triply charged ion at 930.023 was the most abundant signal generated from synthetic human hepcidin-25 sprayed into the mass spectrometer at 5 μM ( Figure 1A) . Addition of sub-stoichiometric CuSO 4 generates a peak corresponding to the triply charged hepcidin-copper complex at an m/z value of 950.329 ( Figure 1B) . The m/z value change between the mono-isotopic triply charged peaks of free hepcidin and the hepcidin-copper complex equates to the complex being 60.9 Da heavier than the free hepcidin. The most abundant isotope of copper (69 %) has an atomic mass of 62.9. Thus there is a loss of 2 Da and 2 positive charges when the complex is formed, indicating that 2 H + ions are lost during complex formation. The addition of equimolar copper to the hepcidin-25 was sufficient for all of the hepcidin to exist as the hepcidin-copper complex ( Figure 1C ).
Copper binding to human hepcidin
To further characterize copper binding to human hepcidin, mass spectra were obtained using 5 μM hepcidin and 0-50 μM CuSO 4 ( Figure 2A ). Human hepcidin-25 binds copper with an affinity such that at 5 μM hepcidin and 5 μM Cu 2+ no free hepcidin is detectable. In contrast, only approx. 20 % of hepcidin-20 exists as a copper complex at 50 μM Cu 2+ , clearly demonstrating that the high-affinity copper binding requires the presence of the Nterminal five residues of hepcidin. Changing the histidine residue at position 3 to an alanine residue also reduces the affinity of hepcidin for copper, with 15-20 μM Cu 2+ being required for 50 % complex formation with hepcidin(H3A). The very high affinity of hepcidin-25 for copper was further explored by decreasing the hepcidin concentration to 1 μM and adding copper in 0.2 μM increments ( Figure 2B ). Stoichiometric copper was sufficient for complete complex formation (in several independent repeats, saturation was obtained at 0.8 Cu 2+ ion per hepcidin, suggesting an overestimation of the hepcidin concentration by approx. 25 %). This experiment indicates that the dissociation constant for Cu 2+ binding to hepcidin-25 is well below 1 μM. A more accurate estimate was difficult to obtain, as the mass spectra became unreliable below 1 μM hepcidin.
Copper binding to murine hepcidin-25 and mutant hepcidin(N3A)
The affinity of murine hepcidin for copper was substantially lower than that of human hepcidin, with approx. 8 μM CuSO 4 required for 50 % complex formation. (Figure 3 ) As with human hepcidin the residue at position 3 appeared to be involved in the binding, because when this asparagine residue was replaced with an alanine residue there was an approx. 5-fold decrease in the affinity for Cu 2+ [approx. 40 μM Cu 2+ required for 50 % complex formation with hepcidin(N3A)] (Figure 3) .
Binding of other transition metal ions to human hepcidin
We tested the ability of 200 μM iron [FeSO 4 200 μM Cu 2+ hepcidin-metal complexes containing two or three metal ions were detectable (results not shown).
Metal binding to urinary hepcidin
The most intense signal in the mass spectrum of hepcidin-25 purified from human urine was a triply charged ion at an m/z value of 930.022, i.e. identical with that of synthetic hepcidin-25. No hepcidin-copper complex was observed in the absence of exogenous CuSO 4 addition. This was as expected, because the hepcidin purification included HPLC in acid conditions, which would have removed any bound metal ions. As with the synthetic peptide, the addition of stoichiometric CuSO 4 resulted in the disappearance of the hepcidin peak and the appearance of a peak corresponding to the triply charged hepcidin-copper complex at an m/z value of 950.325. The theoretical and experimentally determined masses of all the hepcidin peptides used in the present study and their copper complexes are presented in Table 1 . Theoretical masses were calculated from published hepcidin sequences and adjusted for the four internal disulfide bonds present in folded hepcidin [10, 11] . The calculated isotopic distribution (on the basis of the empirical formula of hepcidin including four disulfide bonds) and measured isotopic distribution for hepcidin-25 and hepcidin-25 complexed with copper are shown in Figure 5 . The close agreement between theoretical and measured m/z values and isotopic distributions demonstrate that we are measuring monomeric hepcidin with or without a single bound metal ion. We also used collisioninduced dissociation to obtain MS/MS (tandem MS) spectra of both free hepcidin and the hepcidin-copper complex. Similar fragmentation patterns were obtained in both cases, although in the complex the y22 fragment ion (residues 4-25) predominated, whereas the y21 fragment ion (residues 5-25) was the most intense fragment of free hepcidin (results not shown). Titration of 1 μM urinary hepcidin with increasing concentrations of CuSO 4 ( Figure 6 ) produced a binding curve very similar to that obtained
Table 1 Theoretical and measured masses of hepcidin peptides and their complexes with copper
Shown are the mono-isotopic masses calculated from the amino acid sequence and the predicted m/z ratios of the triply charged ions of these peptides. All calculated masses include adjustment for the presence of four internal disulfide bonds. The calculated masses for the copper complexes include loss of two H + ions during complex formation. We also show the m/z value ratios determined by FTICR mass spectrometry and the mono-isotopic molecular masses calculated from these. The sequences of the hepcidin peptides are shown with amino acid substitutions underlined. The hepcidin-20 used in the present study incorporated a stable-isotope-labelled phenylalanine residue indicated by an asterisk (plus 10 Da). with synthetic hepcidin (Figure 3) , showing near complete binding of Cu 2+ at all CuSO 4 concentrations. This shows that native human hepcidin can bind Cu 2+ with a dissociation constant 1 μM.
Effect of hepcidin peptides on FPN expression in Caco-2 and HEK-293T cells
To determine if the substitution of the histidine residue for an alanine residue influenced the biological activity of hepcidin, the intestinal cell line Caco-2 was challenged with hepcidin-25, hepcidin-25(H3A) or hepcidin-20 followed by determination of FPN levels by Western blotting. In agreement with previous studies [15] , challenging with hepcidin-25, but not hepcidin-20, caused a decrease in FPN levels (P < 0.05) However, substitution of the histidine residue in position 3 for an alanine residue [hepcidin-25(H3A)] abrogated the ability of hepcidin to decrease FPN expression ( Figures 7A and 7B ). In support of this observation, utilizing the well-characterized HEK-293T FPN-GFP assay we observed a statistically significant (P < 0.05) decrease in GFP fluorescence with both human urinary purified hepcidin-25 and synthetic hepcidin-25, but not with hepcidin-25(H3A) ( Figure 7C ). 
Figure 8 Effect of murine hepcidin peptides on murine serum iron levels
Peptides corresponding to hepcidin-25 (Hepc-25) and hepcidin-25(N3A) were injected into wild-type CD1 male mice and after 4 h serum iron levels were assessed relative to mice injected with saline alone (Control). Results are expressed as the means + − S.E.M. (n = 3), *P < 0.05, Student's t test.
Effect of hepcidin peptides on murine serum iron levels
To determine the biological importance of the asparagine residue at position 3 in murine hepcidin-25 both wild-type and N3A mutated hepcidins were injected into wild-type CD1 male mice ( Figure 8 ). As expected, wild-type hepcidin caused a significant hypoferraemic effect after 4 h compared with control mice that received saline alone (P < 0.05). Injecting mice with the murine hepcidin-25(N3A) peptide did not induce a significant hypoferraemia.
DISCUSSION
We have used electrospray FTICR (Fourier-transform ion cyclotron resonance) MS to characterize the binding of several transition metal ions to hepcidin. This technique has previously been used to study metal ion binding to peptides and small proteins [21, 22] and the use of non-denaturing conditions has allowed us to investigate the specificity, affinity and stoichiometry of metal ion binding to hepcidin. Hepcidin-metal complexes were observed with copper, nickel and zinc with a gradient of highest-to-lowest affinity as follows: Cu 2+ >Ni 2+ >Zn 2+ . Hepcidin binds copper with a dissociation constant 1 μM. Our data are consistent with previous work in terms of the metal specificity and the affinity of the ATCUN motif for copper [21, 23] . Indeed, the pioneering work of Lau et al. [23] demonstrated that both the ATCUN motif in albumin and also a short synthetic peptide containing an ATCUN motif bind copper with sub-femtomolar dissociation constants.
Most of our data were obtained using synthetic hepcidin, however, there has been controversy with regards the structure of hepcidin [15, 16] and whether synthetic hepcidin and 'native' hepcidin have identical properties. We therefore examined this metal-hepcidin interaction with hepcidin purified from human urine. The results of the present study show that hepcidin purified from human urine can bind copper with high affinity, excluding the possibility that such an interaction is only a property of synthetic hepcidin. However, using synthetic hepcidin allowed us to make several variants of hepcidin to further characterize copper binding. Hepcidin-20 showed vastly reduced copper binding, indicating that the high-affinity site resides within residues 1-5. Moreover, and as expected, the histidine residue at position 3 plays a crucial role and substituting this for an alanine residue greatly decreases the affinity of hepcidin for copper. The sequence of hepcidin is highly conserved across 23 mammalian species and the N-terminal region is particularly highly conserved. The entire sequence is identical in nine primates, but the N-terminal six residues are identical in all the mammalian hepcidins except rodents (rat and mouse), where His-3 is replaced by an asparagine residue. We find that this amino acid substitution results in greatly reduced copper affinity, although the asparagine residue does support some copper binding, as shown by the further decrease in copper affinity when the asparagine residue is replaced with an alanine residue.
Introducing an alanine residue at position 3 in human hepcidin not only decreases metal binding, but also biological activity, as shown by decreased FPN expression in both Caco-2 and HEK-293T cells. With respect to the murine hepcidin data, we again demonstrate decreased copper binding upon substitution of an asparagine residue at position 3 for an alanine residue, and this amino acid change also appears to decrease biological activity, as shown by a lack of a hypoferraemic response in mice. However, we cannot exclude the possibility that the mutant hepcidin retains some biological activity not detected under these experimental conditions. Furthermore, detailed studies would be required to determine whether the loss of metal binding is responsible for the observed effects, whether the amino acid substitutions cause changes in the structural/biophysical properties of hepcidin and whether the presence of the bulky histidine/asparagine side chain plays a crucial role in determining biological activity.
The data presented in the present study support the report of Melino et al. [17] where hepcidin-metal binding (copper and nickel) was observed using spectroscopic methods. However, we failed to demonstrate any interaction between hepcidin and ferric or ferrous iron as previously reported by Farnaud et al. [18, 19] . We speculate that this is due to a difference in the form of hepcidin used in these previous studies, with our study using the biologically active fully folded form of hepcidin as opposed to the reduced linear form of hepcidin used by Farnaud et al. [18, 19] .
Given the affinities determined in the present study and the circulating levels of the various transition metals in human serum, the only interaction which is likely to be physiologically relevant is that of copper binding to the N-terminal region of hepcidin. The vast majority of plasma copper is in complex with ceruloplasmin; however, free copper may be as high as 0.2 μM in healthy individuals and elevated to 1 μM in patients with Wilson's disease [24] , i.e. sufficiently high to promote complex formation with hepcidin. The residues comprising the copper-binding site are also crucial for the ability of hepcidin to regulate iron metabolism [15, 16] . It is likely that copper binds to this region of hepcidin in a similar manner to other reported ATCUN-copper interactions [23] : co-ordination of the metal ion by the N-terminal amine group, the amide groups of residues 2 and 3 and the imidazole group of the histidine. The resulting conformational restraints on the N-terminal region of hepcidin (which appears to be disordered in NMR and crystal structures [10, 11] ) would alter its ability to bind to FPN and/or other binding partners in vivo.
In summary, we have shown that hepcidin has a very high affinity for copper ions in vitro. We also show that the amino acid residues essential for copper binding are also essential for biological activity. Further work is required to investigate whether copper-hepcidin binding plays a role in iron and/or copper homoeostasis.
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